HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in HTG Molecular Diagnostics, Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +1 vs. Q3 2021
- Shares held
- 2.68M
- −201.0K (−7.0%) vs. Q3 2021
- Total value
- $14.5M
- −$1.92M (−11.7%) vs. Q3 2021
- New holders
- 5
- 2 more added
- Sold out
- 4
- 8 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HTGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 12 | $67.3K |
| Q4 2022 | 10 | $66.2K |
| Q3 2022 | 19 | $283.0K |
| Q2 2022 | 22 | $622.0K |
| Q1 2022 | 22 | $3.19M |
| Q4 2021 | 23 | $14.5M |
| Q3 2021 | 23 | $16.4M |
| Q2 2021 | 25 | $19.7M |
| Q1 2021 | 23 | $11.2M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding HTG Molecular Diagnostics, Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 612,000 | $3.32M | 1.04% | 00.0% | Unchanged |
| Cowen Prime Advisors LLC | 593,133 | $3.21M | 1.09% | −105,400−15.1% | Reduced |
| Samjo Capital LLC | 590,000 | $3.20M | 2.14% | −70,000−10.6% | Reduced |
| Nantahala Capital Management, LLC | 335,015 | $1.82M | 0.11% | −12,156−3.5% | Reduced |
| Vanguard Group Inc | 245,766 | $1.33M | 0.00% | −300−0.1% | Reduced |
| Worth Venture Partners, LLC | 143,135 | $776.0K | 0.38% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 54,616 | $296.0K | 0.00% | −1,300−2.3% | Reduced |
| Geode Capital Management, LLC | 46,039 | $249.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 15,811 | $85.0K | 0.00% | +282+1.8% | Added |
| State Street Corp | 14,043 | $76.0K | 0.00% | 00.0% | Unchanged |
| Kellett Schaffner Wealth Advisors LLC | 11,333 | $61.0K | 0.05% | +11,333 | New |
| HighMark Wealth Management LLC | 6,966 | $38.0K | 0.02% | 00.0% | Unchanged |
| Allworth Financial LP | 3,327 | $18.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,830 | $15.0K | 0.00% | −1,389−32.9% | Reduced |
| UBS Group AG | 2,238 | $12.0K | 0.00% | −470−17.4% | Reduced |
| Migdal Insurance & Financial Holdings Ltd. | 1,316 | $7.00K | 0.00% | −793−37.6% | Reduced |
| Fortitude Advisory Group L.L.C. | 288 | $2.00K | 0.00% | +288 | New |
| Wells Fargo & Company | 40 | $0 | 0.00% | +1+2.6% | Added |
| TCI Wealth Advisors, Inc. | 26 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 13 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 27 | $0 | 0.00% | +27 | New |
| Surevest, LLC | 1 | $0 | 0.00% | +1 | New |
| Cornerstone Advisory, LLC | 1 | $0 | 0.00% | +1 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −15,722−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −3,333−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,997−100.0% | Sold out |
| Ironwood Financial, llc | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Sonora Investment Management, LLC | – | – | – | – | Not filed |